That's the advantage of being a market maker. If you look closely at the minimum share blocks to trade, sometimes only 1 share is needed. And the spreads they have. They can make a killing. On a 7 buck stock, they can have spreads as wide as 50 cents. takes only 1 share to bring it down and turn around for a quick sale.
Good bashing try!!!! It's 10 mil out of the 100 mil shelf. It's on NASDAQ now with big name behind the sale. Low prices are gone. Like you!
that's not correct. There are plenty of big name biotech's that were bought in Phase 2. IN fact, for large share purchases, that's the time to buy in, before PH 2 positive results start drifting in, which is before the huge run up.
Purely a basher or completely uneducated. These designations are never rubber stamped. Have you seen how many they have given out this year?!! Of course not, because an informed person could never state what you just did. Wonder what other aliases you go under dpeters? I.M.A.Peter?!!
This is the first of many things coming. This news hasn't hit mainstream yet. More news is going to hit people blindside. Do you want to be greedy and get the stock for 20 cents cheaper when you can miss out on large PPS movements? That'll be the question over the next 6 weeks.
Not only are you a paid basher, but an immature investor too! You still have no supporting data to justify any of your childish comments and everyone can see that. Hilarious but pitiful at the same time. Not sure what your intent on this forum is?? You can't be here to just post negative statements unless !. You are a paid basher and/or 2. You invested long ago and are bitter that Phase 1 took so long (which investing in any biotech in Phase 1 does and comes with inherent risks) and/or 3. You lost a ton of money waiting for all the positive ground-breaking news on Phase 1 trials and your bitterness and immaturity keeps you here and/or 3. You take pleasure in just being an immature idiot on a board to provoke arguments for arguments sake. Which one is it? Or is it all of them?
Wrong!! Once again, you are just being over eager and just spouting things, just as bad as a basher. They will not uplist in NOV for sure from what they said at the meeting. DEC will be unlikely, which I was thinking they would do before their medical conference, but that isn't going to happen. I was initially upset about that, but then their strategy moving forward is just fine. They mentioned JAN 7th as the 90 day period for uplisting, but that is only one of several methods to uplist. They will uplist most likely early JAN, is my guess but not later than FEB. They have lots of other things going on in the background that is affecting their decision. Potential JV'ing, release of other data, etc…. They are doing great and everyone is highly optimistic leaving the meeting.
I like your enthusiasm, but you sound too much like a "pumper" or an immature investor. Chill out with these statements with no support. Not seeing you haven't put out good data and info before, but it's absurd when you put out 3-10 posts in a row with one line pumping statements. I think this stock will take off and there is lots of supporting data that says this will be the next Regeneron, but lets keep it somewhat professional.
People keep reasking the same question over and over. There are several ways to uplist. One is 90 days from the post r/s and it's put's the date on Jan 7th. (stated in the meeting). They can legally uplist now with another method, but they are being smart on their selection. They will uplist within 2-3 months. They have a strategy. new website by next week and name change imminent. Then all the medical roadshows, and the start of PHASE 2 in UK and the US. The US is a big surprise. They have a bunch of things cooking in the background. A lot of potential JV oppornuties in programs other than AMD/SMD. With the newly proposed higher fee amount per eye to be 100K, not 10K, there revenue is projected to be 10 times higher than all the previous estimates. Even, if it's less than 100K, it solidifies there 10K per eye forecasts. This will be the next best thing since Regeneron. I'm not just spouting out opinions without justifications like the paid bashers on this board. I put them on "Ignore User" anyhow, which everyone should have done by now. If you are still engaging them, then you are part of the problem. I have no problems with negative articles to go with positive articles, since both sides are trying to justify using facts. It's easier to counter incorrect statements or errors so everyone can see them. Listening to bashers that throw out useless opinions is just as bad as something like NMIRIAM that keeps saying "buy before it takes off forever"! Saying these statements are "Pumping" or if not a pumper, then just sounds immature, and put them on "Ignore User" too.
Really?? Only 120K shares have traded hands and the market is closing. Stock is down 2.2%. Wow, that's a really significant amount of non-believers. (rolling my eyes). The only selling happened right after they heard the uplist won't be for another few months and the shares were quickly bought. You are out to lunch! No to put you on 'block' since you have proven yourself a paid basher unable to justify your criticisms.
Anyone that understands this will be the hottest stock since Regeneron!!! That's who? This stock is definitely taking off; it's a matter of how soon, and I rather have this new management team do it the right way. They have a lot going on behind the scenes.
I don't have a problem correcting myself, unlike all the bashers out there. Everything did get passed as planned at the meeting. Extremely positive. The uplist will not occur before the medical conference in beginning of DEC (which I was hoping for, but it's really not that important now). The uplist will occur no later than 60-90 days. What's important is all the things going on in the background with potential JV'ing, other programs, Phase 2 implementation beginning in UK by DEC, and now the US !!
Demetergreen, were you at the ASM? Don't think so. It wasn't a number pulled out of the air. The trials are extremely successful and warrants the higher price. Plus Phase 2 trials don't just commence in the UK in DEC but in the US as well. And the uplist will be done before the 60-90 day period. Most likely early JAN. And they have couple of companies already looking at JV'ing for the blood platelet program, never mind what's going on with the SMD and AMD programs. There was nothing negative to take from the meeting, except those that wanted an uplist now. The new website up by next week, and new name is imminent. Everything got approved at the meeting and everyone left excited. I mean everyone. Nothing you will be able to contradict here.
It's funny how quickly bashers try to bury a good post to page 2 and beyond by putting up a ton of other posts!! Well this is back on Page 1, dang it !!!
Yes, all requirement are met. There are multiple ways to uplist and after they vote tomorrow, which all items will get approved like the authorized shares, will fulfill all necessary requirements for an immediate uplist. Some people keep referring to a 90 day deadline, which is true for a different set of criteria. Could they go that route? Sure, but it's highly unlikely since they have a bunch of things on the near horizon that they want the institutional investors to be able to participate once they hear the most current data and news like the DEC medical conference they will be attending as Ocata Therapeutics.
No audio or video, which is the way it should be for an annual shareholder meeting that will have private information for shareholders and analysts. If you are a non shareholder then the CC on Monday was the one you wanted to be in on.
You are correct and so many people keep saying it's 90 days. 90 days applies to other minimums and their are multiple ways to uplift. They can uplist at any time. They aren't going to do it until they change the name, which will be approved tomorrow. And they get approval for the new authorized shares which they will get as well. Once that is done, they will definitely uplist before the end of the year. Question is how soon? I think it will be before the medical conference they will be presenting at in DEC. Then these idiot bashers can go home, since they will have no affect on the stock.